BI Asset Management Fondsmaeglerselskab’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.4M | Buy |
65,214
+326
| +0.5% | +$132K | 0.26% | 83 |
|
|
2025
Q1 | $32.3M | Buy |
64,888
+2,272
| +4% | +$1.13M | 0.36% | 58 |
|
|
2024
Q4 | $32.6M | Buy |
62,616
+50,015
| +397% | +$26M | 0.34% | 58 |
|
|
2024
Q3 | $7.8M | Sell |
12,601
-2,184
| -15% | -$1.35M | 0.14% | 139 |
|
|
2024
Q2 | $8.18M | Buy |
14,785
+3,305
| +29% | +$1.83M | 0.13% | 147 |
|
|
2024
Q1 | $6.67M | Buy |
11,480
+2,234
| +24% | +$1.3M | 0.13% | 143 |
|
|
2023
Q4 | $4.91M | Sell |
9,246
-3,786
| -29% | -$2.01M | 0.1% | 168 |
|
|
2023
Q3 | $6.6M | Sell |
13,032
-37,978
| -74% | -$19.2M | 0.15% | 122 |
|
|
2023
Q2 | $26.6M | Buy |
51,010
+2,798
| +6% | +$1.46M | 0.63% | 41 |
|
|
2023
Q1 | $27.8M | Sell |
48,212
-9,217
| -16% | -$5.31M | 0.74% | 34 |
|
|
2022
Q4 | $31.6M | Buy |
57,429
+54,493
| +1,856% | +$30M | 0.84% | 27 |
|
|
2022
Q3 | $1.49M | Sell |
2,936
-1,681
| -36% | -$853K | 0.08% | 153 |
|
|
2022
Q2 | $2.51M | Buy |
+4,617
| New | +$2.51M | 0.11% | 136 |
|
|
2022
Q1 | – | Sell |
-604
| Closed | -$403K | – | 521 |
|
|
2021
Q4 | $403K | Buy |
+604
| New | +$403K | 0.01% | 344 |
|
|
2021
Q3 | – | Sell |
-38,246
| Closed | -$19.3M | – | 402 |
|
|
2021
Q2 | $19.3M | Buy |
38,246
+5,086
| +15% | +$2.57M | 0.74% | 41 |
|
|
2021
Q1 | $15.1M | Buy |
33,160
+20,150
| +155% | +$9.2M | 0.62% | 52 |
|
|
2020
Q4 | $6.06M | Buy |
13,010
+11,943
| +1,119% | +$5.56M | 0.26% | 88 |
|
|
2020
Q3 | $471K | Buy |
+1,067
| New | +$471K | 0.02% | 363 |
|